These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22708602)

  • 21. Calcium-permeable AMPA channels in neurodegenerative disease and ischemia.
    Kwak S; Weiss JH
    Curr Opin Neurobiol; 2006 Jun; 16(3):281-7. PubMed ID: 16698262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
    Louzada PR; Paula Lima AC; Mendonca-Silva DL; Noël F; De Mello FG; Ferreira ST
    FASEB J; 2004 Mar; 18(3):511-8. PubMed ID: 15003996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ampakine CX516 ameliorates functional deficits in AMPA receptors in a hippocampal slice model of protein accumulation.
    Kanju PM; Parameshwaran K; Sims C; Bahr BA; Shonesy BC; Suppiramaniam V
    Exp Neurol; 2008 Nov; 214(1):55-61. PubMed ID: 18687330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabotropic glutamate receptors modulate glutamatergic and GABAergic synaptic transmission in the central nucleus of the inferior colliculus.
    Farazifard R; Wu SH
    Brain Res; 2010 Apr; 1325():28-40. PubMed ID: 20153735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons.
    Xia YF; Arai AC
    Neuroscience; 2005; 135(2):555-67. PubMed ID: 16125852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT(1A) and 5-HT(7) receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission.
    Costa L; Trovato C; Musumeci SA; Catania MV; Ciranna L
    Hippocampus; 2012 Apr; 22(4):790-801. PubMed ID: 21538661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of AMPA receptor-mediated ion current by pituitary adenylate cyclase-activating polypeptide (PACAP) in CA1 pyramidal neurons from rat hippocampus.
    Costa L; Santangelo F; Li Volsi G; Ciranna L
    Hippocampus; 2009 Jan; 19(1):99-109. PubMed ID: 18727050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.
    Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J
    J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.
    Mellor IR
    Future Med Chem; 2010 May; 2(5):877-91. PubMed ID: 21426207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two families of TARP isoforms that have distinct effects on the kinetic properties of AMPA receptors and synaptic currents.
    Cho CH; St-Gelais F; Zhang W; Tomita S; Howe JR
    Neuron; 2007 Sep; 55(6):890-904. PubMed ID: 17880893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excitotoxicity and ALS: what is unique about the AMPA receptors expressed on spinal motor neurons?
    Kawahara Y; Kwak S
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):131-44. PubMed ID: 16183555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,3-benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects.
    Szénási G; Vegh M; Szabo G; Kertesz S; Kapus G; Albert M; Greff Z; Ling I; Barkoczy J; Simig G; Spedding M; Harsing LG
    Neurochem Int; 2008 Jan; 52(1-2):166-83. PubMed ID: 17707550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic potential of positive AMPA receptor modulators in the treatment of neurological disease.
    Yamada KA
    Expert Opin Investig Drugs; 2000 Apr; 9(4):765-78. PubMed ID: 11060708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of AMPA receptor function in relation to glutamatergic abnormalities in Alzheimer's disease.
    Madsen U; Ebert B; Krogsgaard-Larsen P
    Biomed Pharmacother; 1994; 48(7):305-11. PubMed ID: 7858161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPA receptor inhibitors for the treatment of neurological disorders.
    Niu L
    Future Med Chem; 2014 May; 6(8):849-952. PubMed ID: 24962276
    [No Abstract]   [Full Text] [Related]  

  • 40. Endocytosis of AMPA receptors: Role in neurological conditions.
    Bencsik N; Oueslati Morales CO; Hausser A; Schlett K
    Prog Mol Biol Transl Sci; 2023; 196():59-97. PubMed ID: 36813366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.